Announcements
- Trading update for the year ended 30 June 2024
- Appointment of Nominated Adviser and Sole Broker
- Launch of new Company Long Term Incentive Plan
- Appointment of Non-Executive Director
- Progression of patient cohorts in PROTECT Trial
- Successful meetings with Paul Ehrlich Institut
- Allergy Therapeutics presents findings at EAACI
- Further detail from G306 Phase III field trial
- Director Resignation
- Interim Results for six months ended 31 Dec 2023
More ▼
Key statistics
As of last trade Allergy Therapeutics PLC (AGYTF:PKC) traded at 0.06, 0.00% below its 52-week high of 0.06, set on Jul 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.06 |
---|---|
High | 0.06 |
Low | 0.06 |
Bid | -- |
Offer | -- |
Previous close | 0.06 |
Average volume | -- |
---|---|
Shares outstanding | 4.77bn |
Free float | 336.83m |
P/E (TTM) | -- |
Market cap | 228.79m GBP |
EPS (TTM) | -0.0266 GBP |
Data delayed at least 15 minutes, as of Jul 15 2024 17:12 BST.
More ▼